Phenotypic expression of polycystic ovary syndrome in South Asian women

Obstetrical and Gynecological Survey

Volumn 68, Issue 3, 2013, Pages 228-234

  Mehta, Jay ^a   Kamdar, Vikram ^b   Dumesic, Daniel ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ENDOCRINE DISRUPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; LUTEINIZING HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B BETA; SOMATOMEDIN C; TRANSCRIPTION FACTOR YAP1;

ACNE; ANOVULATION; BIRTH RATE; BODY MASS; CULTURAL FACTOR; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; ETHNICITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HEREDITY; HIRSUTISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; MOTHER FETUS RELATIONSHIP; NONHUMAN; OOCYTE RETRIEVAL; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PROTEIN PHOSPHORYLATION; REVIEW; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; SOCIAL STATUS;

ASIA, SOUTHEASTERN; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; FEMALE; HUMANS; INFERTILITY, FEMALE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME;

EID: 84874832340     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318280a30f     Document Type: Review

References (67)

1. Dumesic D, Abott D. Accounting for the follicle population in the polycystic ovary. In: Dunaif A CR, Franks S, Legro RS, eds. Polycystic Ovary Syndrome; Current Controversies, From the Ovary to the Pancreas. Totowa, NJ: Human Press Inc.; 2008:9-24.
2. Azziz R, Carmina E,Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237-4245.
3. Vendola KA, Zhou J, Adesanya OO, et al. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622-2629.
4. Weil S, Vendola K, Zhou J, et al. Androgen and folliclestimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951-2956.
5. Weil SJ, Vendola K, Zhou J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab. 1998; 83:2479-2485.
6. Welt CK, Arason G, Gudmundsson JA, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab. 2006;91:4361-4368.
7. Rodin DA, Bano G, Bland JM, et al. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol. 1998;49:91-99.
8. Wijeyaratne CN, Balen AH, Barth JH, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol. 2002;57:343-350.
9. Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219-231.
10. Wood JR, Dumesic DA, Abbott DH, et al. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab. 2007;92: 705-713.
11. Allahbadia GN, Merchant R. Polycystic ovary syndrome in the Indian Subcontinent. Semin Reprod Med. 2008;26:22-34.
12. Gluszak O, Stopinska-Gluszak U, Glinicki P, et al. Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol. 2012;2012:569862.
13. Palep-Singh M, Picton HM, Vrotsou K, et al. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. Eur J Obstet Gynaecol Reprod Biol. 2007;134:202-207.
14. Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, et al. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod. 2011;26: 202-213.
15. Shahine LK, Lamb JD, LathiRB, et al. Poor prognosis with in vitro fertilization in Indian women compared to Caucasian women despite similar embryo quality. PloS One. 2009;4:e7599.
16. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004;82:661-665.
17. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83:1454-1460.
18. Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab. 2005;90:3236-3242.
19. Norman RJ,Masters L, Milner CR, et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or noninsulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod. 2001;16:1995-1998.
20. Moran LJ,MissoML,Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16:347-363.
21. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800.
22. Baillargeon JP, Nestler JE. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab. 2006;91:22-24.
23. Balen AH, Conway GS, Homburg R, Legro RS. Polycystic Ovary Syndrome. A Guide to Clinical Management. London: Taylor and Francis; 2005.
24. Franks S, Gilling-Smith C, Watson H, et al. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am. 1999;28:361-378.
25. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139-146.
26. Bergh C, Carlsson B, Olsson JH, et al. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril. 1993;59:323-331.
27. Goverde AJ, van Koert AJ, Eijkemans MJ, et al. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod. 2009;24:710-717.
28. Holte J, Gennarelli G, Wide L, et al. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 1998;83:1143-1150.
29. Apridonidze T, Essah PA, Iuorno MJ, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90: 1929-1935.
30. Ehrmann DA, Liljenquist DR, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:48-53.
31. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038-2049.
32. Wijeyaratne CN, Nirantharakumar K, Balen AH, et al. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol. 2004;60:560-567.
33. Dunaif A, Sorbara L, Delson R, et al. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 1993;42:1462-1468.
34. Ehrmann DA, Kasza K, Azziz R, et al. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90:66-71.
35. Lear SA, Kohli S, Bondy GP, et al. Ethnic variation in fat and lean body mass and the association with insulin resistance. J Clin Endocrinol Metab. 2009;94:4696-4702.
36. Krishnaveni GV, Hill JC, Veena SR, et al. Truncal adiposity is present at birth and in early childhood in South Indian children. Indian Pediatr. 2005;42:527-538.
37. Yajnik CS, Fall CH, Coyaji KJ, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes. 2003;27:173-180.
38. Whincup PH, Gilg JA, Papacosta O, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ. 2002;324:635.
39. Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat D. 2009;7:497-514.
40. Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factorsVan Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97:1-61.
41. Wijeyaratne CN, Waduge R, Arandara D, et al. Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus. BJOG. 2006;113:1182-1187.
42. Jenum AK, Morkrid K, Sletner L, et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol. 2012;166:317-324.
43. Makgoba M, Savvidou MD, Steer PJ. An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG. 2012;119:276-282.
44. AmatoP, SimpsonJL. Thegenetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynecol. 2004;18:707-718.
45. Vink JM, Sadrzadeh S, Lambalk CB, et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91:2100-2104.
46. Ewens KG, Stewart DR, Ankener W, et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab. 2010;95:2306-2315.
47. Urbanek M, Woodroffe A, Ewens KG, et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab. 2005;90:6623-6629.
48. Hatzirodos N, Bayne RA, Irving-Rodgers HF, et al. Linkage of regulators of TGF-beta activity in the fetal ovary to polycystic ovary syndrome. FASEB J. 2011;25:2256-2265.
49. Goodarzi MO, Jones MR, Chen YD, et al. First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care. 2008;31:2284-2287.
50. Jones MR, Mathur R, Cui J, et al. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17betahydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab. 2009;94:5034-5038.
51. Wood JR, Nelson VL, Ho C, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem. 2003;278:26380-26390.
52. Zhao H, Xu X, Xing X, et al. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Hum Reprod. 2012;27:294-298.
53. Welt CK, Styrkarsdottir U, Ehrmann DA, et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012; 97:E1342YE1347.
54. Mukherjee S, Shaikh N, Khavale S, et al. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Eur J Endocrinol. 2009;160:855-862.
55. Dasgupta S, Sirisha P, Neelaveni K, et al. Polymorphisms in the IRS-1 and PPAR-gamma genes and their association with polycystic ovary syndrome among South Indian women. Gene. 2012;503:140-146.
56. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11 suppl 1):S9YS30.
57. Clark AM, Thornley B, Tomlinson L, et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13:1502-1505.
58. Guzick DS, Wing R, Smith D, et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril. 1994;61:598-604.
59. Carmina E, Legro RS, Stamets K, et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. 2003;18:2289-2293.
60. Misra A, Khurana L, Isharwal S, et al. South Asian diets and insulin resistance. Br J Nutr. 2009;101:465-473.
61. Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001;131:871SY873S.
62. BorkmanM,Campbell LV, Chisholm DJ, et al.Comparison of the effects on insulin sensitivity of high carbohydrate and high fat diets in normal subjects. J Clin Endocrinol Metab. 1991;72: 432-437.
63. Kandaraki E, Chatzigeorgiou A, Livadas S, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab. 2011;96:E480YE484.
64. Takeuchi T, Tsutsumi O, Ikezuki Y, et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J. 2004;51:165-169.
65. Mapes M. Rx for reducing health disparities in type 2 diabetes. Endocr News. 2012:38-41.
66. Alberti K, Zimmet P, Shaw J, et al. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Foundation: Brussels, Belgium; 2006.
67. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109: 433-438.